/ /

  • linkedin
  • Increase Font
  • Sharebar

    PRK enhancement after SMILE favorable after short follow-up

    Surface ablation performed with mitomycin-C (MMC) seems to be a safe and effective technique for treating residual refractive error after myopic SMILE, said Martin Dirisamer, MD.

    Dr. Dirisamer’s conclusion was based on findings from a retrospective study that included 40 eyes followed for 3 months after undergoing PRK as an enhancement

    He noted that significant reduction in MRSE was achieved within 1 week after PRK, and the achieved MRSE was stable to month 3. Uncorrected visual acuity (UCVA) was significantly improved by the 6-week visit and remained stable through the available follow-up.

    At 3 months, mean MRSE was 0.03 ± 0.57 D and mean UCVA was 0.08 ± 0.15 logMAR. There were two cases of significant overcorrection and two cases of significant undercorrection.

    Beginning at 6 weeks postPRK, mean corrected distance visual acuity (CDVA) was equal to the pre-enhancement level. The procedure had a safety index of 1.06.

    Six eyes (15%) lost 1 line of CDVA, but even in those eyes, CDVA at 3 months was 20/20 or 20/25.

    “Of course long-term results are necessary to evaluate the efficacy and safety of surface ablation as a touch-up technique,” said Dr. Dirisamer, cornea consultant, Ludwig-Maximilians-University of Munich, Germany, and co-owner SMILE EYES Clinic, Linz, Austria.

    “And, it is also necessary to compare outcomes using different enhancement techniques,” he added.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results